Alpha Tau Medical (DRTS) Stock

Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Alpha Tau Medical in August 2026.

Sixth Month Growth Performance

$15.00

+7.65 (104.08%)past 6 months

≈

Stock Performance Snapshot

Strong Buy

Analyst Rating

Analysts highly recommend buying Alpha Tau Medical’s stock due to strong growth potential.

Average

Financial Health

Alpha Tau Medical is showing reasonable cash flow and book value per share for a young company.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

View more stocks by downloading the app for FREE

It only takes 60 seconds.

Why invest with Nemo?

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

Alpha Tau Medical (DRTS) Stock: Price, Analysis & 2026 Outlook

Compare Alpha Tau Medical with other stocks

Southern First vs Alpha Tau Medical

Southern First Bancshares serves business clients in South Carolina and Georgia markets as a straightforward community bank while Alpha Tau Medical develops alpha-particle radiation therapy targeting solid tumors in clinical trials. Both companies are small-cap names where a single catalyst can reprice the stock dramatically. The Southern First vs Alpha Tau Medical comparison makes clear just how wide the gap is between a predictable community banking business model and a binary clinical-stage biotech.

Runway Growth Finance vs Alpha Tau Medical

Runway Growth Finance operates as a business development company extending debt capital to late-stage venture-backed companies, while Alpha Tau Medical develops alpha radiation therapy for cancer treatment and remains in a pre-commercial clinical stage. Both companies target growth-oriented businesses, but Runway lends capital while Alpha Tau consumes it. The Runway Growth Finance vs Alpha Tau Medical comparison highlights how a BDC generating interest income from startup lending contrasts with a clinical-stage medical device company betting on binary regulatory and commercial outcomes.

Alpha Tau Medical vs MBIA

Alpha Tau Medical is a development-stage biotech advancing targeted alpha radiation therapy through clinical trials without commercial revenue, while MBIA runs a financial guarantee and insurance business managing legacy structured finance exposures from the 2008 financial crisis. Both companies carry significant uncertainty about future cash flows, but from completely different sources. The Alpha Tau Medical vs MBIA comparison puts clinical pipeline risk alongside legacy liability run-off risk, showing how each company's path to value realization depends on entirely different catalysts and timelines.

Alpha Tau Medical (DRTS) Stock

Sixth Month Growth Performance

Stock Performance Snapshot

Analyst Rating

Financial Health

Why invest with Nemo?

Zero Commission

Trusted & Regulated

Alpha Tau Medical (DRTS) Stock

About This Stock

Sixth Month Growth Performance

Stock Performance Snapshot

Analyst Rating

Financial Health

Why invest with Nemo?

Zero Commission

Trusted & Regulated

About This Stock

6% Interest on Cash

baskets-featuring

Radiopharma Revolution: Promise Meets Market Risk

Discover More Opportunities

RUM GROUP INC

COMPASS DIVERSIFIED

CANNAE HOLDINGS INC

Compare Alpha Tau Medical with other stocks

Southern First vs Alpha Tau Medical

Runway Growth Finance vs Alpha Tau Medical

Alpha Tau Medical vs MBIA